Company ThermoGenesis Holdings, Inc.

Equities

THMO

US88362L2097

Office Equipment

Market Closed - Nasdaq 04:30:00 2024-03-27 pm EDT 5-day change 1st Jan Change
0.7032 USD +0.59% Intraday chart for ThermoGenesis Holdings, Inc. -2.94% +17.00%

Business Summary

ThermoGenesis Holdings, Inc. develops and commercializes a range of automated technologies for cell-banking, cell-processing, and cell-based therapeutics. It provides the AutoXpress and BioArchive platforms for automated clinical bio-banking, PXP platform for point-of-care cell-based therapies and the CAR-TXpress platform for large scale cell manufacturing services. Its products include Clinical Bio-Banking Applications, Point-of-Care Applications and Large-Scale Cell Processing and Biomanufacturing. Its Clinical Bio-Banking Applications include AXP Automated Cell Separation System and BioArchive Automated Cryopreservation System. Its Point-of-Care Applications include PXP Point-of-Care System, PXP-LAVARE System and PXP-1000 System. Its Large-Scale Cell Processing and Biomanufacturing includes X-Series Products for general laboratory use and CAR-TXpress Platform for Clinical Manufacturing. AXP Automated Cell Separation System is an automated, fully closed cell separation system.

Number of employees: 41

Sales per Business

USD in Million2021Weight2022Weight Delta
Device
81.4 %
7 76.7 % 9 81.4 % +19.68%
Service
15.6 %
2 19.8 % 2 15.6 % -10.93%
Other
3.0 %
0 3.5 % 0 3.0 % -3.98%

Sales per region

USD in Million2021Weight2022Weight Delta
United States
63.4 %
0 0.0 % 7 63.4 % -
China
18.9 %
-- 2 18.9 % -
Other
7.6 %
-- 1 7.6 % -
Vietnam
4.9 %
-- 1 4.9 % -
South Korea
3.1 %
-- 0 3.1 % -
Portugal
2.0 %
-- 0 2.0 % -
Thailand
0.1 %
-- 0 0.1 % -

Managers

Managers TitleAgeSince
Chief Executive Officer 53 16-03-09
Director of Finance/CFO 51 09-12-31
Investor Relations Contact - -

Members of the board

Members of the board TitleAgeSince
Director/Board Member 69 17-02-23
Director/Board Member 78 17-01-09
Chief Executive Officer 53 16-03-09
Director/Board Member 53 16-11-02
Director/Board Member - 23-07-13

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 7,952,780 2,809,363 ( 35.33 %) 0 35.33 %

Shareholders

NameEquities%Valuation
4,440,279 42.91 % 4 M $
Raymond James & Associates, Inc.
0.6282 %
65,004 0.6282 % 56 488 $
Vanguard Group, Inc. (Subfiler)
0.3423 %
35,419 0.3423 % 30 779 $
Two Sigma Securities LLC
0.2298 %
23,776 0.2298 % 20 661 $
Citadel Securities GP LLC
0.2032 %
21,028 0.2032 % 18 273 $
Geode Capital Management LLC
0.0995 %
10,300 0.0995 % 8 951 $
Morgan Stanley Capital Services LLC
0.0898 %
9,294 0.0898 % 8 076 $
Tower Research Capital LLC
0.0745 %
7,714 0.0745 % 6 703 $
UBS Securities LLC
0.0649 %
6,719 0.0649 % 5 839 $
BlackRock Institutional Trust Co. NA
0.0144 %
1,493 0.0144 % 1 297 $

Company contact information

ThermoGenesis Holdings, Inc.

2711 Citrus Road

95742, Rancho Cordova

+916 858 5100

http://www.thermogenesis.com
address ThermoGenesis Holdings, Inc.(THMO)